SGPSpyGlass Pharma Inc.

$18.19
$0.55
(2.94%)
Today
Closed $18.19
$0.36
(1.98%)
After Hours
Updated: 05:38 PM EDT
Reported EarningsMay 14
Mkt Cap$626.54M
Vol70,141.00

About

SpyGlass Pharma, Inc. is a late-stage biopharmaceutical, which engages in the development of treatment paradigm for patients living with chronic eye conditions. Its lead product candidate, Bimatoprost Drug Pad-IOL System (BIM-IOL System), is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) for patients who have wither open-angel glaucoma (OAG) or ocular hypertension (OHT). The company was founded in January 2019 by Malik Y. Kahook and Glenn Sussman and is headquartered in Aliso Viejo, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
65

Frequently Asked Questions

What is Market Cap of SpyGlass Pharma Inc.?
What is the 52-week high for SpyGlass Pharma Inc.?
What is the 52-week low for SpyGlass Pharma Inc.?
What is SpyGlass Pharma Inc. stock price today?
What was SpyGlass Pharma Inc. stock price yesterday?
What is the Price-to-Book ratio of SpyGlass Pharma Inc.?
What is the 50-day moving average of SpyGlass Pharma Inc.?
How many employees does SpyGlass Pharma Inc. have?

Advertisement|Remove ads.